FNDC5 and sarcopenia: Since the levels of coenzyme Q10 and skeletal muscle protein biomarkers were significantly associated with the risk of sarcopenia, we suggest that coenzyme Q10, irisin, and creatine kinase may be candidate markers that could assist in the diagnosis of sarcopenia.